Dr. Kishore Narra
Lead Scientist-Formulation at Anticancer Bioscience- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English -
-
Hindi -
-
Telugu -
-
Tamil -
Topline Score
Bio
Credentials
-
Diagnostic and Prognostic Use of Clinical imaging, Immuno Histochemical Methods and Bio-markers for Cancer in Animals
Ministry of Science &Technology, Department of Biotechnology (DBT).May, 2012- Nov, 2024 -
Animal Tissue Culture and Advanced Molecular Biology Techniques’
MSME Development Institute, Govt. of India, Chennai.Jun, 2010- Nov, 2024
Experience
-
Anticancer Bioscience
-
China
-
Biotechnology
-
1 - 100 Employee
-
Lead Scientist-Formulation
-
Jul 2022 - Present
-
-
-
Sami-Sabinsa Group Limited
-
India
-
Pharmaceutical Manufacturing
-
400 - 500 Employee
-
Senior Scientist - Drug Delivery System
-
Dec 2018 - Jun 2022
•.Led proof-of-concept projects on lipid-based delivery (Self-emulsifying Drug Delivery System) for solubility enhancement of Curcumin,Tetra Hydro Curcumin and Resveratrol. Prepared novel solid dispersion composition and oral solution for challenging API (Curcumin and Tetra Hydro Curcumin) for bioavailability enhancement. Follow-up literature (scientific and patent) in order to create new development opportunities for pharmaceutical development •.Led proof-of-concept projects on lipid-based delivery (Self-emulsifying Drug Delivery System) for solubility enhancement of Curcumin,Tetra Hydro Curcumin and Resveratrol. Prepared novel solid dispersion composition and oral solution for challenging API (Curcumin and Tetra Hydro Curcumin) for bioavailability enhancement. Follow-up literature (scientific and patent) in order to create new development opportunities for pharmaceutical development
-
-
-
-
POST DOC RESEARCH FELLOW
-
Jan 2015 - Jul 2018
Research work focuses on Silica-lipid hybrid nanoparticles: Improving the oral delivery of poorly soluble drugs and surface functionalized lipid based drug delivery system for effective management of Asthma. Research work focuses on Silica-lipid hybrid nanoparticles: Improving the oral delivery of poorly soluble drugs and surface functionalized lipid based drug delivery system for effective management of Asthma.
-
-
-
Venus Remedies Limited
-
India
-
Pharmaceutical Manufacturing
-
400 - 500 Employee
-
Formulation Research and Development(VMRC), Asst Manager
-
Nov 2012 - May 2014
Project initiated and work done on formulation development of solid lipid nanoparticle formulation (Combination of Ceftriaxone and Sulbactum) as a switch over therapy from IV dose to Oral delivery. Project initiated and work done on formulation development of solid lipid nanoparticle formulation (Combination of Ceftriaxone and Sulbactum) as a switch over therapy from IV dose to Oral delivery.
-
-
-
CSIR- CENTRAL LEATHER RESEARCH INSTITUTE
-
Chennai , India
-
JRF- JUNIOR RESEARCH FELLOW & SRF- SENIOR RESEARCH FELLOW
-
Mar 2008 - Nov 2012
Formulation optimization by using ‘Design Expert’ software by QbD approach. Formulation & Optimization of Aceclofenac and Celecoxib Loaded Lyophilized Solid Lipid Nanoparticles. Formulation & Optimization of Repaglinide Loaded Poly Methyl Methacrylate (PMMA) & Poly-lactide Glycolic Acid (PLGA) Injectable Nanoparticles. Preparation and Characterization of Rifampicin Loaded Alginate Beads. Formulation and Characterization of Poly herbal tablets. Pharmacokinetics, Toxicological and Pharmacological evaluation of Anti-arthritic, Anti-diabetic, Wound healing, Analgesic, Anti-pyretic & Anti-ulcer activity of natural and synthetic compounds.
-
-
Education
-
2008 - 2012
CSIR CLRI
-
2008 - 2012
Central Leather Research Institute( CSIR- CLRI), Madras University- Chennai
Ph.D( Pharmaceutics), Novel drug Delivery System, Rheumatoid Arthrities -
2006 - 2008
Bharathidasan University- BIT, Tiruchirapalli, Tamilnadu
M.Pharmacy, Pharmaceutics -
2001 - 2005
Sri Padmavathi School of Pharmacy, Tirupathi- JNTU (Hyderabad)
Bachelor of Pharmacy (B.Pharm.)
Community
